Stocks · News reference
Sunshine Biopharma Inc. Scheduled to Announce Q3 2026 Financial Results
Sunshine Biopharma Inc. has scheduled the release of its third-quarter 2026 financial results for November 10, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
Dow Falls Over 100 Points; US Initial Jobless Claims Decline
U.S. stocks fell Thursday, led by tech, while energy rose and oil jumped 4.8%. Jobless claims eased to 197,000; small caps posted sharp swings.
Sunshine Biopharma shares are trading lower after the company announced the pricing of its $6 million offering of 10,909,083 units at $0.55 per unnit.
Sunshine Biopharma Prices ~$6M Public Offering Of 10,909,083 Units At $0.55/Unit, Each With Two Warrants Exercisable At $0.66
US Stocks Mixed; Nasdaq Gains Over 50 Points
U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; oil fell, while gold, silver and copper gained.